[Designer-drugs in tumor treatment]

Area of Science:

• Oncology and Hematology
• Molecular Biology
• Pharmacology

Background:

• Conventional chemotherapy affects general cell division and nucleic acid metabolism.
• Targeted therapies leverage molecular understanding of cancer, including chromosomal translocations and tumor survival requirements.
• Advances in basic science enable the development of precision medicine strategies.

Purpose of the Study:

• To summarize targeted therapeutic strategies in hematology and oncology.
• To highlight the transition of these approaches from research (bench) to clinical application (bedside).
• To contrast targeted therapies with conventional chemotherapy.

Main Methods:

• Review of current targeted therapeutic concepts.
• Focus on small molecules and monoclonal antibodies.
• Analysis of molecular targets such as translocation products, surface molecules, and survival pathways.

Main Results:

• Targeted approaches demonstrate superior efficacy compared to conventional chemotherapy.
• These novel treatments are expected to have a better side effect profile in the long term.
• Several targeted strategies have successfully translated to clinical practice.

Conclusions:

• Targeted therapies represent a paradigm shift in treating hematologic and oncologic malignancies.
• Understanding the molecular basis of cancer is crucial for developing effective and safer treatments.
• The future of cancer therapy lies in personalized, molecularly-driven approaches.